Blog
RSS FeedPosted by Michael Wonder on 27 Mar 2018
Health consumer choice drives better care
27 March 2018 - Giving people greater choice in human services including health would give consumers more control over their ...
Posted by Michael Wonder on 27 Mar 2018
Proposal to fund aflibercept and rivaroxaban
27 March 2018 - PHARMAC is seeking feedback on a proposal to list aflibercept (Eylea) and rivaroxaban (Xarelto) through a ...
Posted by Michael Wonder on 26 Mar 2018
Young Canadians feeling the pinch of sky-high prescription drug prices
26 March 2018 - Use of Ontario’s public drug program has increased three fold since 2000, which suggests that young ...
Posted by Michael Wonder on 26 Mar 2018
Canada probes Horizon Pharma over efforts to boost sales of a rare disease drug
26 March 2018 - Canadian authorities are reviewing whether Horizon Pharma violated pricing and advertising laws in connection with its ...
Posted by Michael Wonder on 26 Mar 2018
Doctors name and shame health insurers as profits and complaints soar
26 March 2018 - Doctors have exposed the best and worst private health insurers in a new report card that ...
Posted by Michael Wonder on 26 Mar 2018
PBS legislative amendments
26 March 2018 - The Department is finalising guidance material on the amendments to the National Health Act 1953 relating ...
Posted by Michael Wonder on 26 Mar 2018
Rejected by the Government, I've spent $160,000 just to keep myself alive
25 March 2018 - Jess Spence currently pays for her Neuroendocrine cancer treatment in Melbourne, Australia. PHARMAC are still to decide ...
Posted by Michael Wonder on 26 Mar 2018
Cheaper medicine for thousands of Australian patients
26 March 2018 - The Australian Government will drastically reduce the cost of medicines to treat diabetes, cancer, arthritis, asthma and ...
Posted by Michael Wonder on 25 Mar 2018
Fresh hopes that breast cancer drug Perjeta will be made available in Scotland
22 March 2018 - Breast cancer campaigners have welcomed talks aimed at making a life-extending drug available to women in ...
Posted by Michael Wonder on 25 Mar 2018
Medicines to treat asthma diabetes, arthritis, cancer and eye disease added to PBS
26 March 2018 - The Federal Government will slash the price that patients pay for 11 medicines used to treat asthma, ...
Posted by Michael Wonder on 22 Mar 2018
What is the evidence from past NICE single-technology appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY?
22 March 2018 - NICE has recently proposed that company submissions with a base-case incremental cost-effectiveness ratio of less than ...
Posted by Michael Wonder on 22 Mar 2018
Resolving the “cost-effective but unaffordable” paradox: estimating the health opportunity costs of non-marginal budget impacts
22 March 2018 - Considering whether or not a proposed investment (an intervention, technology, or program of care) is affordable is ...
Posted by Michael Wonder on 22 Mar 2018
Affordability of new technologies: the next frontier
22 March 2018 - Affordability, or rather a lack of it, has become a new buzzword in health policy. It is ...
Posted by Michael Wonder on 22 Mar 2018
Harmonised health technology assessment in Europe? There’s a long way to go
22 March 2018 - Europe is heading towards harmonisation in health technology assessment – but great differences remain in practices ...
Posted by Michael Wonder on 22 Mar 2018
Psoriasis patients get NHS access to LEO Pharma’s Kyntheum
22 March 2018 - Cost regulators for NHS therapies in England and Wales have now published final guidelines backing the ...